Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Lars, Bärfacker"'
Autor:
Lars Bärfacker, Peter Kolkhof
Publikováno v:
The Journal of Endocrinology
The cDNA of the mineralocorticoid receptor (MR) was cloned 30 years ago, in 1987. At that time, spirolactone, the first generation of synthetic steroid-based MR antagonists (MRAs), which was identified in preclinicalin vivomodels, had already been in
Autor:
Ningshu Liu, Franziska Siegel, Lars Bärfacker, Franz von Nussbaum, Karl Ziegelbauer, Ulf Bömer, William J. Scott, Stuart Ince, Amaury Ernesto Fernandez-Montalvan, Dominik Mumberg, Kirstin Meyer, Roland Neuhaus, Martin Michels, Oliver Politz, Andrea Hägebarth
Publikováno v:
International Journal of Cancer. 140:449-459
The PI3K-AKT-mTOR signaling cascade is activated in the majority of human cancers, and its activation also plays a key role in resistance to chemo and targeted therapeutics. In particular, in both breast and prostate cancer, increased AKT pathway act
Autor:
Dieter Lang, Ulrich Rosentreter, Franz von Nussbaum, Heike Gielen-Haertwig, Volkhart Min-Jian Li, Michael Gerisch, Martin Bechem, Helmut Haning, Dagmar Karthaus, Leila Telan, Martina Schäfer, Lars Bärfacker, Joachim Mittendorf, Sonja Anlauf, Klemens Lustig, Adrian Tersteegen, Daniel Meibom, Jens Schamberger, Swen Allerheiligen, Fitzgerald Mary F, Stefan Schäfer, Martina Delbeck
Publikováno v:
Chemmedchem
Human neutrophil elastase (HNE) is a key protease for matrix degradation. High HNE activity is observed in inflammatory diseases. Accordingly, HNE is a potential target for the treatment of pulmonary diseases such as chronic obstructive pulmonary dis
Autor:
Oliver, Politz, Franziska, Siegel, Lars, Bärfacker, Ulf, Bömer, Andrea, Hägebarth, William J, Scott, Martin, Michels, Stuart, Ince, Roland, Neuhaus, Kirstin, Meyer, Amaury Ernesto, Fernández-Montalván, Ningshu, Liu, Franz, von Nussbaum, Dominik, Mumberg, Karl, Ziegelbauer
Publikováno v:
International journal of cancer. 140(2)
The PI3K-AKT-mTOR signaling cascade is activated in the majority of human cancers, and its activation also plays a key role in resistance to chemo and targeted therapeutics. In particular, in both breast and prostate cancer, increased AKT pathway act
Publikováno v:
Nuclear Receptors as Drug Targets
Autor:
F. Josef van der Staay, Heike Heckroth, Kris Rutten, Christina Erb, Martin Hendrix, Arjan Blokland, Adrian Tersteegen, Marja Van Kampen, Dagmar Karthaus, Ulrich H. Schröder, Klaus G. Reymann, Jos Prickaerts, Jean DeVry, Lars Bärfacker
Publikováno v:
Neuropharmacology, 55(5), 908-918. Elsevier Science
The present study investigated the putative pro-cognitive effects of the novel selective PDE9 inhibitor BAY 73-6691. The effects on basal synaptic transmission and long-term potentiation (LTP) were investigated in rat hippocampal slices. Pro-cognitiv
Autor:
Peter Kolkhof, Stefan Schäfer, Axel Kretschmer, Barbara Albrecht-Küpper, Martina Delbeck, Lars Bärfacker, Frank Eitner, Elke Hartmann, Wolfram Steinke
Publikováno v:
Journal of cardiovascular pharmacology. 64(1)
Pharmacological blockade of the mineralocorticoid receptor (MR) ameliorates end-organ damage in chronic heart failure. However, the clinical use of available steroidal MR antagonists is restricted because of concomitant hyperkalemia especially in pat
Publikováno v:
European Journal of Organic Chemistry. 2000:1131-1135
Autor:
Christian Buss, Beate E. Kitsos-Rzychon, Lars Bärfacker, Andreas Schmidt, Christian L. Kranemann, Rafael Roggenbuck, Thorsten Rische, Peter Eilbracht, Christoph Hollmann
Publikováno v:
Chemical Reviews. 99:3329-3366
Publikováno v:
European Journal of Organic Chemistry. 1999:1907-1914